|
May 10
|
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
|
|
May 9
|
Alpine Immune Sciences Reports First Quarter 2024 Financial Results
|
|
May 7
|
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
|
|
May 7
|
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
|
|
May 7
|
Vertex Pharmaceuticals Inc (VRTX) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...
|
|
May 7
|
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
|
|
Apr 18
|
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
|
|
Apr 15
|
Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?
|
|
Apr 15
|
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
|
|
Apr 13
|
Could This Stock Be the Next Biotech Buyout?
|
|
Apr 12
|
Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex
|
|
Apr 12
|
Health Care Roundup: Market Talk
|
|
Apr 11
|
These Stocks Moved the Most Today: CarMax, Apple, Fastenal, Rivian, Alpine Immune, Nike, Robinhood, Constellation Brands, and More
|
|
Apr 11
|
Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal
|
|
Apr 11
|
Stocks to Watch Thursday: Robinhood, Alpine Immune, Constellation Brands
|
|
Apr 11
|
Vertex Pharmaceuticals Seeks a Second Act With Alpine Immune Deal. What Wall Street Says.
|
|
Apr 11
|
These Stocks Are Moving the Most Today
|
|
Apr 11
|
Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer
|
|
Apr 10
|
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
|